YUNAMARI
Live / Applied — Non-final action mailed (as of 18 May 2026)
What this means for you
Not registered yet, but its 07 Apr 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99749581
- Mark type
- Word mark
- Filed
- 07 Apr 2026
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases, blood diseases, bone and skeletal diseases, cancer, cardiovascular diseases, sleep apnea, central nervous system diseases, cluster headaches, coronavirus disease, and Crohn's disease; Pharmaceutical preparations for treating dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammatory diseases and disorders, kidney diseases, liver diseases, lupus, and mental disorders; Pharmaceutical preparations for treating metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative or neurological diseases and disorders, obesity, chronic weight management, osteoarthritis, pain, Parkinson's disease, psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and vascular diseases; Pharmaceutical preparations
Owner
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 18 May 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 18 May 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 18 May 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 May 2026 — NON-FINAL ACTION E-MAILED
- 18 May 2026 — NON-FINAL ACTION WRITTEN
- 14 May 2026 — ASSIGNED TO EXAMINER
- 07 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 07 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 07 Apr 2026 — NEW APPLICATION ENTERED